New Review of Academic Fellow Rachel Sachs on Fecal Transplants
Rachel E. Sachs' new paper "Ensuring the Safe and Effective FDA Regulation of Fecal Microbiota Transplantation," coauthored with Carolyn Edelstein, has been reviewed by Nicholas Bagley on The Incidental Economist. From the review:
The paper is full of fascinating stuff [...] including Sachs’s and Edelstein’s bottom-line recommendation that FDA ought to treat stool more like cord blood and other tissues than as a conventional drug. Go read it!
Check out the full review!
Image via Wikimedia Commons. Author Cjc2nd.
Read the Full Review
Tags
fda health law policy human tissue pharmaceuticals public health rachel sachs regulation